Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada

Pediatric Infectious Disease Journal

Volumn 17, Issue 9 SUPPL., 1998, Pages

  Wenger, Jay D ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Canada; Haemophilus influenzae; Hib; United States; Vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

BACTERIAL INFECTION; BACTERIAL MENINGITIS; CANADA; CHILDHOOD MORTALITY; CONFERENCE PAPER; DISEASE TRANSMISSION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VACCINATION;

CANADA; CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 0031689122     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809001-00008     Document Type: Conference Paper

References (22)

1. Ward J, Lieberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia: Saunders, 1994.
2. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987;6: 779-82.
3. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV, Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1991;162:1316-23.
4. Granoff DM, Basden M. Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis 1980;141:40-6.
5. Parke JC Jr, Schneerson R, Robbins JB. The attack rate, age incidence, racial distribution, and case fatality rate of Haemophilus influenzae type b meningitis in Mecklenberg County, North Carolina. J Pediatr 1972;81:765-9.
6. Redmond SR, Pichichero ME. Haemophilus influenzae type b disease: an epidemiologic study with special reference to day-care centers. JAMA 1984;252:2581-4.
7. Ward JI, Lum MKW, Hall DB, et al. Invasive H. influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis 1986;108:887-96.
8. Istre GR, Conner JS, Broome CV, Hightower AW, Hopkins RS. Risk factors for primary invasive Haemophilus influenzae disease: increased risk from day care attendance and school-aged household members. J Pediatr 1985;106:190-5.
9. Cochi SL, Fleming DW, Hightower AW, et al. Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr 1986;108:887-6.
10. Wenger JD, Harrison LH, Hightower AW, Broome CV, Haemophilus influenzae study group: day care characteristics associated with Haemophilus influenzae disease. Am J Public Health 1990;80:1455-8.
11. Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influenzae type b disease in Southern California. Arch Pediatr Adolesc Med 1994;148:51-6.
12. Wenger JD, Pierce R, Deaver KA, Plikaytis BD, Facklam RR, Broome CV. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet 1991;338:395-8.
13. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children: United States, 1987-1995. MMWR 1996;45:901-6.
14. Schlech WF, Ward JI, Band JD, Hightower AW, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981: the National Bacterial Meningitis Surveillance Study. JAMA 1985;253:1749-54.
15. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
16. Schoendorf KC, Adams WG, Kiely JL, Wenger JD. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 1994;93:663-8.
17. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
18. Murphy TV, Pastor P, Medley R, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
19. Mohle-Boetani JC, Ajello G, Breneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
20. Jafari H, Adams W, Deaver KA, et al. Efficacy of Haemophilus influenzae type b (Hib) conjugate vaccines, risk factors for disease and under-vaccination in the United States [Abstract G-12]. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17 to 20, 1995.
21. Laboratory Centre for Disease Control. Notifiable diseases annual summary: Supplement, 1994. Can Comm Dis Rep 1996;22S2:63-4.
22. Immunization monitoring program, active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control. Recent trends in pediatric Haemophilus influenzae type b infections in Canada. Can Med Assoc J 1996;154:1041-7.